Literature DB >> 23521465

Evolving role of FDG PET/CT in multiple myeloma imaging and management.

Ankit Agarwal1, Alin Chirindel, Bhartesh A Shah, Rathan M Subramaniam.   

Abstract

OBJECTIVE: Multiple myeloma is the most common cause of primary malignancy in bones. Radiography has been the imaging reference standard for decades. However, the growing use of CT, MRI, and PET technology has led to earlier diagnosis of multiple myeloma, more accurate therapy assessment, and better prediction of patient outcome. This article is focused on the evolving role of (18)F-FDG PET/CT in multiple myeloma diagnosis, therapy assessment, and prognosis.
CONCLUSION: FDG PET/CT is a valuable imaging modality in diagnosis, therapy assessment, and prognosis of multiple myeloma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23521465     DOI: 10.2214/AJR.12.9653

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  15 in total

Review 1.  Imaging of multiple myeloma: Current concepts.

Authors:  Thorsten Derlin; Peter Bannas
Journal:  World J Orthop       Date:  2014-07-18

2.  Clinical relevance of PET/CT in patients with newly diagnosed multiple myeloma.

Authors:  Chaoyu Wang; Ling Wu; Chengtao Sun; Yizhuo Zhang
Journal:  Int J Clin Exp Pathol       Date:  2019-02-01

3.  [Radiological diagnostics of multiple myeloma].

Authors:  M D'Anastasi; S Grandl; M F Reiser; A Baur-Melnyk
Journal:  Radiologe       Date:  2014-06       Impact factor: 0.635

4.  Imaging Melphalan Therapy Response in Preclinical Extramedullary Multiple Myeloma with 18F-FDOPA and 18F-FDG PET.

Authors:  Deep K Hathi; Elizabeth N DeLassus; Samuel Achilefu; Jonathan McConathy; Monica Shokeen
Journal:  J Nucl Med       Date:  2018-04-26       Impact factor: 10.057

5.  Follow-up or Surveillance (18)F-FDG PET/CT and Survival Outcome in Lung Cancer Patients.

Authors:  Alexander J Antoniou; Charles Marcus; Abdel K Tahari; Richard L Wahl; Rathan M Subramaniam
Journal:  J Nucl Med       Date:  2014-04-28       Impact factor: 10.057

Review 6.  Brain PET in the diagnosis of Alzheimer's disease.

Authors:  Charles Marcus; Esther Mena; Rathan M Subramaniam
Journal:  Clin Nucl Med       Date:  2014-10       Impact factor: 7.794

7.  In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.

Authors:  Kathrin Philipp-Abbrederis; Ken Herrmann; Stefan Knop; Margret Schottelius; Matthias Eiber; Katharina Lückerath; Elke Pietschmann; Stefan Habringer; Carlos Gerngroß; Katharina Franke; Martina Rudelius; Andreas Schirbel; Constantin Lapa; Kristina Schwamborn; Sabine Steidle; Elena Hartmann; Andreas Rosenwald; Saskia Kropf; Ambros J Beer; Christian Peschel; Hermann Einsele; Andreas K Buck; Markus Schwaiger; Katharina Götze; Hans-Jürgen Wester; Ulrich Keller
Journal:  EMBO Mol Med       Date:  2015-04       Impact factor: 12.137

8.  Targeting paraprotein biosynthesis for non-invasive characterization of myeloma biology.

Authors:  Katharina Lückerath; Constantin Lapa; Annika Spahmann; Gerhard Jörg; Samuel Samnick; Andreas Rosenwald; Herrmann Einsele; Stefan Knop; Andreas K Buck
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

9.  Diffusion weighted magnetic resonance imaging demonstrates tumor response following palliative embolization of a recurrent shoulder plasmacytoma.

Authors:  Viktor Bérczi; Gábor Rudas; Lajos Rudolf Kozák; Tamás Györke; Gábor Mikala; Tamás Masszi; Ildikó Kalina; Pál Novák Kaposi
Journal:  World J Surg Oncol       Date:  2014-08-22       Impact factor: 2.754

10.  Advantages of Combined PET-CT in Mediastinal Staging in Patients with Non-small Cell Lung Carcinoma.

Authors:  Nermina Beslic; Amera Sadija; Renata Milardovic; Timur Ceric; Sejla Ceric; Adnan Beganovic; Spomenka Kristic; Semra Cavaljuga
Journal:  Acta Inform Med       Date:  2016-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.